SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN) -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (242)1/25/2000 9:00:00 PM
From: phbolton  Read Replies (2) | Respond to of 523
 
Thomas: As the other long term NRGN poster I also thought that the eyeglass post was inane as it contained zero information.
Somewhat surprised that NRGN held up as well as it did today.
AIDD could offer a $100-200 mil in revenues over the next couple of years.



To: Thomas M. who wrote (242)1/25/2000 9:58:00 PM
From: scaram(o)uche  Read Replies (2) | Respond to of 523
 
>> I've never heard of the guy. <<

You should forgive Miljenko's outburst. He's really a nice guy. He's also under intense pressure to repeat his '99 performance so that he can buy Croatia, rather than just visit, next time he feels like going home.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News